Dr. Ventura is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200
Education & Training
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2013 - 2016
University of Brasilia Foundation Faculty of MedicineClass of 2012
Certifications & Licensure
IL State Medical License 2016 - 2026
CT State Medical License 2018 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Clinical Trials
- High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19 Start of enrollment: 2020 Apr 20
Roles: Contact
Publications & Presentations
PubMed
- Stressful life events are associated with the diagnosis of systemic autoimmune rheumatic diseases among adults.Iazsmin Bauer Ventura, Maya E Goldberg, Adam Schiffenbauer, Min Shi, Rita Volochayev
Clinical and Experimental Rheumatology. 2025-01-01 - Clinical Characteristics of Anti-synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project.Sara Faghihi-Kashani, Akira Yoshida, Francisca Bozan, Giovanni Zanframundo, Davide Rozza
Arthritis & Rheumatology. 2024-10-28 - 9 citationsAgreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank.Aravinthan Loganathan, Giovanni Zanframundo, Akira Yoshida, Sara Faghihi-Kashani, Iazsmin Bauer Ventura
Clinical and Experimental Rheumatology. 2024-02-01
Press Mentions
Clinical Trial to Study New Use for CAR T-cell Therapy: Treating Autoimmune DiseasesJanuary 21st, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
